CStone completes VOYAGER trial enrollment in Chinese patients

Pharma |  News | 0 Comment | 16 Dec, 2019

CStone Pharmaceuticals has announced that the on-going, global Phase III VOYAGER clinical trial of avapritinib, an investigational drug discovered by CStone's partner, Blueprint Medicines, ...Read more

Eisai breaks ground for global drug discovery centre

Pharma |  News | 0 Comment | 16 Dec, 2019

Japan based Eisai Co., Ltd. has had a groundbreaking ceremony for a major renovation of its Tsukuba Research Laboratories (Ibaraki, Japan) as part of strategic investment to realize Eisai&r...Read more

AT & IT China 2020 to showcase intelligent pharma solutions

Pharma |  News | 0 Comment | 13 Dec, 2019

AT & IT China 2020, organized by Informa Markets and China Chamber of Commerce for Import & Export of Medicines & Health Products and co-organized by Shanghai Sinoexpo...Read more

Solasia enters new license alliance with Maruho

Pharma |  News | 0 Comment | 11 Dec, 2019

Japan based Solasia Pharma K.K. has announced that it has entered into an exclusive license agreement with Maruho Co., Ltd. for the commercialization of Solasia’s product SP-04 (PledO...Read more

BI gets recognition as Top Employer 2020 in SEA, South Korea

Pharma |  News | 0 Comment | 11 Dec, 2019

Boehringer Ingelheim has been recognized as a Top Employer across seven countries – Singapore, Malaysia, Philippines, Thailand, Vietnam, Indonesia and South Korea in 2020. Granted by ...Read more

Sanofi to acquire Synthorx for $2.5 B

Pharma |  News | 0 Comment | 09 Dec, 2019

Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a definitive...Read more

Eppendorf with new CEO dual leadership

Pharma |  News | 0 Comment | 06 Dec, 2019

Hamburg, December 6, 2019 – The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Busine...Read more

AstraZeneca receives Chinese marketing nod for Lynparza

Pharma |  News | 0 Comment | 09 Dec, 2019

AstraZeneca and MSD have announced that the companies have received marketing authorisation from China’s National Medical Products Administration (NMPA) for Lynparza (o...Read more

Taiwan Healthcare+ Expo to provide advanced MedTech solutions and B2B opportunities

Pharma |  News | 0 Comment | 05 Dec, 2019

2019 Taiwan Healthcare + Expo is set to stage from 3rd to 6th Dec at Taipei Nangang Exhibition Center. The forum is an exemplar for global health enterprises amalgamation in associatio...Read more

Strides Singapore gets USFDA tentative nod for pain relieving drug

Pharma |  News | 0 Comment | 05 Dec, 2019

Strides Pharma Science Limited (Strides) has announced that its step‐down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received tentative approval for Diclo...Read more

Pharmapack announces key themes for Pharmapack Europe 2020

Pharma |  News | 0 Comment | 04 Dec, 2019

Paris, 03 December 2019:  Connectivity, customization and sustainability are driving pharmaceutical packaging and drug delivery innovation at Pharmapack Europe (#pharmapacke...Read more

RAPT Therapeutics collaborates with Hanmi Pharma

Pharma |  News | 0 Comment | 04 Dec, 2019

US based RAPT Therapeutics, a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patient...Read more

Dong-A ST with Beactica to develop new cancer treatments

Pharma |  News | 0 Comment | 05 Dec, 2019

Dong-A ST Co., Ltd., a Korean pharmaceutical company, and Beactica Therapeutics AB, a Swedish drug discovery company, have announced that a lead compound meeting certain pre-defined criteri...Read more

China NMPA accepts Lenvima for Additional Indication of Thyroid Cancer

Pharma |  News | 0 Comment | 04 Dec, 2019

Tokyo based Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Produ...Read more

Singapore approves new early breast cancer drug

Pharma |  News | 0 Comment | 03 Dec, 2019

A new breast cancer drug shown to significantly reduce the risk of cancer recurrence has received approval in Singapore – at least six months ahead of its expected...Read more

CMAB, Fapon join hands for biologic oncology asset

Pharma |  News | 0 Comment | 03 Dec, 2019

CMAB Biopharma Inc., a pure-play, biologics contract manufacturing and development organization (CDMO) and Shenzhen Fapon Biopharma Inc., an innovative biopharmaceutical company, announced ...Read more

Astellas to acquire Audentes Therapeutics in a $3B deal

Pharma |  News | 0 Comment | 03 Dec, 2019

Japan headquartered Astellas Pharma Inc. and Audentes Therapeutics, Inc. have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, ...Read more

Ascletis gets pharmaceutical trade license and GSP certificate

Pharma |  News | 0 Comment | 02 Dec, 2019

Ascletis Pharma, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseas...Read more